Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,385 public trials 1,303 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension

NCT02960204

Conditions: Cirrhosis, Digestive System Diseases, Fatty Liver, +9 more
Locations: Pasadena Pasadena, California, United States

Rialto Rialto, California, United States

Palmetto Bay Palmetto Bay, Florida, United States

Atlanta Atlanta, Georgia, United States

View all 37 locations

View Trial Details

Completed

Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular Carcinoma

NCT05235490

Conditions: Adenocarcinoma, CT Scans Prior to Surgery With a Least 2 Years of Follow-up, Carcinoma, +9 more
Locations: Paul Brousse Hospital Villejuif, France

View Trial Details

Completed

Way to Cure HCV Adherence

NCT02472925

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Corporal Michael J. Crescenz VA Medical Center Philadelphia, Pennsylvania, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)

NCT03685708

Conditions: Digestive System Diseases, Hepatitis, Liver Diseases, +1 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

NCT03511794

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

NCT03420768

Conditions: Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +5 more
Locations: The Texas Liver Institute San Antonio, Texas, United States

View Trial Details

Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

NCT04811898

Conditions: Adenocarcinoma, Advanced Solid Tumor, Blood Protein Disorders, +24 more
Locations: Center for Phase I Clinical Studies in Medical Oncology and Oncohematology - Translational Medical Oncology Unit, AOU MaterDomini and Magna Graecia University Catanzaro, Italy

View Trial Details

Completed

Field Trial of Maternal Influenza Immunization in Asia

NCT01034254

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +15 more
Locations: Institute of Medicine, Tribhuvan Univerisity Kathmandu, Nepal

View Trial Details

Completed

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

NCT02947165

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations: Sarah Cannon Research Institute SC Nashville, Tennessee, United States

Huntsman Cancer Institute SC Salt Lake City, Utah, United States

Novartis Investigative Site Salzburg, Austria

Novartis Investigative Site Toronto, Ontario, Canada

View Trial Details

Completed

Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome

NCT02358928

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +15 more
Locations: UTexasSouthwestern/Childrens Medical Center Dallas, Texas, United States

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions